Tokushima University / Educator and Researcher Directory --- Bando, Hiroki

Search:

Tokushima University ⟩ University Hospital ⟩ 先端医科医療開発研究プロジェクト ⟩
Tokushima University ⟩ University Hospital ⟩ Clinical Division ⟩ Department of Internal Medicine ⟩ Respiratory and Rheumatology Medicine ⟩
Tokushima University ⟩ Faculty of Medicine ⟩ School of Medicine ⟩ Course of Bioregulation and Medical Oncology ⟩ Respiratory Medicine and Rheumatology ⟩

(Files for researchmap) [PDF manual] [Auto-propagate to researchmap]

Research

Field of Study

Subject of Study

Book / Paper

Academic Paper (Judged Full Paper):

1.	Kaori Nii, Hirokazu Ogino, Hiroki Bando, Yuki Yamamoto, Koji Fujita, Hiroto Yoneda, Nobuhito Naito, Atsushi Mitsuhashi, Yutaka Morita, Yuki Tsukazaki, Yohei Yabuki, Ryohiko Ozaki, Seidai Satou, Masaki Hanibuchi, Yuishin Izumi and Yasuhiko Nishioka : Immune checkpoint inhibitor-associated paraneoplastic cerebellar degeneration in a case of extensive-stage small-cell lung cancer with pre-existing anti-SOX1 antibody, The Journal of Medical Investigation : JMI, 72, 1.2, 172-176, 2025. (Summary) Neurological immune-related adverse events can manifest as paraneoplastic neurological syndrome (PNS), especially in patients with small-cell lung cancer (SCLC). We herein report a 73-year-old man with SCLC treated with an immune checkpoint inhibitor (ICI) combined with chemotherapy. Although the chemo-immunotherapy induced a favorable response to SCLC, he later developed acute cerebellar ataxia. He was diagnosed with paraneoplastic cerebellar degeneration associated with anti-Sry-like high mobility group box 1 (SOX1) autoantibody. The antibody was also identified in serum collected at the diagnosis of SCLC and before ICI administration, which retrospectively suggested that the patient was at risk of ICI-induced PNS. J. Med. Invest. 72 : 172-176, February, 2025. (Keyword) anti-SOX1 autoantibody / immune checkpoint inhibitors / paraneoplastic cerebellar degeneration / small-cell lung cancer (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.72.172 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 40268441 ● Summary page in Scopus @ Elsevier: 2-s2.0-105003981938 (DOI: 10.2152/jmi.72.172, PubMed: 40268441, Elsevier: Scopus)

Proceeding of International Conference:

1.	Kojin Murakamia, Seidai Satou, Yuta Isomura, Trang Hong Thi Phuong, Noriko Bando, Ryoko Suzue, Nandin-Erdene Danzan, Yuya Yamashita, Hiroki Bando, Keiko Haji, Nobuhito Naito, Kozo Kagawa, Hiroshi Kawano, Noriaki Inamura, Kenji Hasumi and Yasuhiko Nishioka : SMTP-44D, a soluble epoxide hydrolase inhibitor, attenuated the progression of pulmonary fibrosis in vivo and in vitro, The ERS Congress 2024, Wien, Sep. 2024.
2.	Keiko Haji, Seidai Satou, Hirohisa Ogawa, Isomura Yuta, Noriko Bando, Suzue Ryoko, Phuong Thi Hong Trang, Danzan Nandin-Erdene, Yuya Yamashita, Murakami Kojin, Hiroki Bando, Nobuhito Naito, Kazuya Koyama, Hiroshi Kawano, Kobayashi Katsutoshi, Morohoshi Toshiro and Yasuhiko Nishioka : The effect of novel autotaxin inhibitor, 2-carba cyclic phosphatidic acid, in lung fibrosis, ATS 2024, San Diego, May 2024.
3.	Seidai Satou, Yamamoto Takushi, Morimoto Yuki, Isomura Yuta, Noriko Bando, Suzue Ryoko, Phuong Thi Hong Trang, Danzan Nandin-Erdene, Yuya Yamashita, Murakami Kojin, Hiroki Bando, Keiko Haji, Nobuhito Naito, Hiroshi Kawano and Yasuhiko Nishioka : Analysis of Local Distribution and Residence Time of Nintedanib in Fibrotic Lung Tissue Using Mass Spectrometry Imaging, ATS 2024, San Diego, May 2024.

Proceeding of Domestic Conference:

1.	Kozo Kagawa, Seidai Satou, Kazuya Koyama, Yuta Isomura, Ryoko Suzue, 村上行人, Hiroki Bando, Keiko Haji and Yasuhiko Nishioka : リンパ球特異的タンパク質チロシンキナーゼ阻害による抗線維化作用の検討, 第4回日本びまん性肺疾患研究会, Sep. 2024.
2.	Seidai Satou, 山本卓志, 森本友樹, Yuta Isomura, Ryoko Suzue, Kojin Murakami, Hiroki Bando, Keiko Haji, Kozo Kagawa and Yasuhiko Nishioka : 質量分析イメージングを用いたニンテダニブの肺内局在分布と滞留時間の検討, 第4回日本びまん性肺疾患研究会, Sep. 2024.
3.	Shotaro Tachibana, Hirohisa Ogawa, Mayuko Shimizu, Hiroki Bando, Seidai Satou, Takahiro Takayama, Koichi Inoue, Yasuhiko Nishioka and Koichi Tsuneyama : 慢性気管支喘息における杯細胞過形成に対するLPA1受容体の役割, Japanese Journal of Allergology, 73, 6/7, 844, Aug. 2024. (Keyword) 気管支喘息 / 粘液産生 / リソフォスファチジン酸 / LPA1 receptor
4.	宮本憲哉, Masaki Hanibuchi, Yuta Isomura, Yutaka Morita, 村上行人, Hiroki Bando, Ryohiko Ozaki, Kozo Kagawa, Hiroto Yoneda, Hirokazu Ogino and Yasuhiko Nishioka : 気管支鏡後の呼吸器感染症ハイリスク症例における予防的抗菌薬投与の意義についての後方視的研究, 第47回日本呼吸器内視鏡学会学術集会, Jun. 2024.
5.	Seidai Satou, 山本卓志, 森本友樹, Noriko Bando, 村上行人, Hiroki Bando, Keiko Haji, Kozo Kagawa and Yasuhiko Nishioka : 質量分析イメージングiMScope QTを用いたニンテダニブの肺内局在分布と滞留時間の検討, 第64回日本呼吸器学会学術講演会, Apr. 2024.
6.	Yu Aoi, Hiroki Bando, Keiko Haji, 高橋啓輝, Hiroto Yoneda, Akane Abe, Seidai Satou, Momoyo Azuma, Masaki Hanibuchi and Yasuhiko Nishioka : 気管支鏡検査で診断したCOVID-19関連肺アスペルギルス症の1例, 第32回日本呼吸器内視鏡学会中国四国支部会, Dec. 2023.

Et cetera, Workshop:

1.	和田津将巳, 村上行人, Hiroki Bando, 坂東紀子, Yohei Yabuki, Nobuhito Naito, Hirokazu Ogino, Seidai Satou, Masaki Hanibuchi and Yasuhiko Nishioka : レンバチニブが奏効したFGFR3変異陽性胸腺癌の1例, 第131回日本内科学会四国地方会, Dec. 2024.
2.	伊藤一輝, 村上行人, Hiroki Bando, 中西渓介, Nobuhito Naito, Hirokazu Ogino, Seidai Satou, Hiroshi Kawano, Masaki Hanibuchi and Yasuhiko Nishioka : 体外式膜型人工肺を導入して救命した関節リウマチ関連間質性肺疾患急性増悪の1例, 第131回日本内科学会四国地方会, Dec. 2024.
3.	磯村祐太, 村上行人, Hiroki Bando, 梶本達也, 近藤圭大, Keiko Haji, Asami Fukuya, Kozo Kagawa, Hirokazu Ogino, Seidai Satou, Masaki Hanibuchi, 辻誠士郎, Tomoyo Hara and Yasuhiko Nishioka : 副腎不全を合併した孤発性の両側副腎結核の一例, 第75回日本結核・非結核性抗酸菌症学会中国四国支部会, Nov. 2024.
4.	Yutaka Morita, 村上行人, Hiroki Bando, 宮本憲哉, 磯村祐太, 梶本達也, 近藤圭大, Kozo Kagawa, Hirokazu Ogino, Seidai Satou, Masaki Hanibuchi and Yasuhiko Nishioka : 気管支鏡で診断した肺内神経鞘腫の一例, 第33回日本呼吸器内視鏡学会中国四国支部会, Nov. 2024.
5.	中西颯斗, 村上行人, Hiroki Bando, 磯村裕太, 梶本達也, 近藤圭大, Kozo Kagawa, Hirokazu Ogino, Seidai Satou, Masaki Hanibuchi and Yasuhiko Nishioka : テポチニブ投与後に高度な血小板減少と好中球減少を来したMET exon14 skipping変異陽性肺腺癌の一例, 第71回日本呼吸器学会中国・四国地方会, Nov. 2024.
6.	近藤圭大, 村上行人, Hiroki Bando, Yuki Tsukazaki, Hirokazu Ogino, 松本利加子, Yutaka Morita, Atsushi Mitsuhashi, Ryohiko Ozaki, Yohei Yabuki, Seidai Satou, Masaki Hanibuchi, 岡野義夫, Souji Kakiuchi, Yuko Toyoda, 長谷加容子, 竹内栄治, 葉久貴司 and Yasuhiko Nishioka : 進展型小細胞肺癌において顆粒球コロニー刺激因子が化学免疫療法の治療効果に及ぼす影響, 第269回徳島医学会学術集会, Jul. 2024.
7.	伊藤一輝, 村上行人, Hiroki Bando, 山本浩生, Yuki Tsukazaki, Nobuhito Naito, Hirokazu Ogino, Seidai Satou, Masaki Hanibuchi and Yasuhiko Nishioka : EGFR L858R 変異陽性肺腺癌に対して CBDCA+nab-PTX+Atezolizumab が pseudoprogression を伴って著効した一例, 第70回日本呼吸器学会中国・四国地方会, Jul. 2024.
8.	和田津将巳, 村上行人, Hiroki Bando, Nobuhito Naito, Seidai Satou, Momoyo Azuma, 佐藤雅美, Masaki Hanibuchi, 中村茂樹, 生方公子, 高田美佐子 and Yasuhiko Nishioka : COVID-19に合併した血清型15A 肺炎球菌による重症肺炎の一例, 第70回日本呼吸器学会中国・四国地方会, Jul. 2024.
9.	山田青季, 村上行人, Hiroki Bando, 中西渓介, Nobuhito Naito, Hirokazu Ogino, Seidai Satou, Masaki Hanibuchi and Yasuhiko Nishioka : ソトラシブが奏効したKRAS G12C変異陽性の肺原発大細胞神経内分泌癌の一例, 第70回日本呼吸器学会中国・四国地方会, Jul. 2024.
10.	坂東紀子, 村上行人, Hiroki Bando, Yuya Yamashita, Nobuhito Naito, Hirokazu Ogino, Seidai Satou, Hiroshi Kawano, Masaki Hanibuchi and Yasuhiko Nishioka : プレドニゾロン，トシリズマブ，リツキシマブの三剤同時併用療法が奏効した治療抵抗性TAFRO症候群の1例, 第130回日本内科学会四国地方会, Jun. 2024.
11.	中西颯斗, 村上行人, Hiroki Bando, 宮本憲哉, 坂東紀子, Nobuhito Naito, Hirokazu Ogino, Seidai Satou, Masaki Hanibuchi and Yasuhiko Nishioka : 包括的ゲノムプロファイリング検査にてPD-L1遺伝子増幅を認めた胸骨原発放射線関連肉腫の1例, 第130回日本内科学会四国地方会, Jun. 2024.